These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 10362090)
1. MCA106 fibrosarcoma cells transduced with granulocyte/macrophage colony-stimulating factor are not superior to the wild-type cells in suppressing the growth of hepatic metastases. Dong XD; Abdel-Wahab Z; Dematos P; Fong T; Pruitt SK; Seigler HF J Surg Oncol; 1999 May; 71(1):36-45. PubMed ID: 10362090 [TBL] [Abstract][Full Text] [Related]
2. Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice. DeMatos P; Abdel-Wahab Z; Vervaert C; Hester D; Seigler H J Surg Oncol; 1998 Jun; 68(2):79-91. PubMed ID: 9624036 [TBL] [Abstract][Full Text] [Related]
3. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells. Cao X; Zhang W; Wang J; Zhang M; Huang X; Hamada H; Chen W Immunology; 1999 Aug; 97(4):616-25. PubMed ID: 10457215 [TBL] [Abstract][Full Text] [Related]
4. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
5. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells. Kinoshita Y; Kono T; Yasumoto R; Kishimoto T; Wang CY; Haas GP; Nishisaka N J Immunother; 2001; 24(3):205-11. PubMed ID: 11394497 [TBL] [Abstract][Full Text] [Related]
7. Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine. Chang EY; Chen CH; Ji H; Wang TL; Hung K; Lee BP; Huang AY; Kurman RJ; Pardoll DM; Wu T Int J Cancer; 2000 Jun; 86(5):725-30. PubMed ID: 10797297 [TBL] [Abstract][Full Text] [Related]
8. Effective immunization against neuroblastoma using double-transduced tumor cells secreting GM-CSF and interferon-gamma. Bausero MA; Panoskaltsis-Mortari A; Blazar BR; Katsanis E J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):113-24. PubMed ID: 8732694 [TBL] [Abstract][Full Text] [Related]
9. Irradiated tumor cells adenovirally engineered to secrete granulocyte/macrophage-colony-stimulating factor establish antitumor immunity and eliminate pre-existing tumors in syngeneic mice. Nagai E; Ogawa T; Kielian T; Ikubo A; Suzuki T Cancer Immunol Immunother; 1998 Oct; 47(2):72-80. PubMed ID: 9769115 [TBL] [Abstract][Full Text] [Related]
10. Paradoxical effect of GM-CSF gene transfer on the tumorigenicity and immunogenicity of murine tumors. Wang J; Yang WK; Yang Y; Wei SJ; Yang DM; Whang-Peng J; Chen YM; Ting KL; Ting CC Int J Cancer; 1998 Jan; 75(3):459-66. PubMed ID: 9455809 [TBL] [Abstract][Full Text] [Related]
11. Vaccination with dendritic cells inhibits the growth of hepatic metastases in B6 mice. DeMatos P; Abdel-Wahab Z; Vervaert C; Seigler HF Cell Immunol; 1998 Apr; 185(1):65-74. PubMed ID: 9636684 [TBL] [Abstract][Full Text] [Related]
12. Vaccine effect of granulocyte-macrophage colony-stimulating factor or CD80 gene-transduced murine hematopoietic tumor cells and their cooperative enhancement of antitumor immunity. Nakazaki Y; Tani K; Lin ZT; Sumimoto H; Hibino H; Tanabe T; Wu MS; Izawa K; Hase H; Takahashi S; Tojo A; Azuma M; Hamada H; Mori S; Asano S Gene Ther; 1998 Oct; 5(10):1355-62. PubMed ID: 9930341 [TBL] [Abstract][Full Text] [Related]
14. Regression of established mouse leukemia by GM-CSF-transduced tumor vaccine: implications for cytotoxic T lymphocyte responses and tumor burdens. Hsieh CL; Pang VF; Chen DS; Hwang LH Hum Gene Ther; 1997 Nov; 8(16):1843-54. PubMed ID: 9382951 [TBL] [Abstract][Full Text] [Related]
15. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. Mach N; Gillessen S; Wilson SB; Sheehan C; Mihm M; Dranoff G Cancer Res; 2000 Jun; 60(12):3239-46. PubMed ID: 10866317 [TBL] [Abstract][Full Text] [Related]
16. Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response. Chiodoni C; Paglia P; Stoppacciaro A; Rodolfo M; Parenza M; Colombo MP J Exp Med; 1999 Jul; 190(1):125-33. PubMed ID: 10429676 [TBL] [Abstract][Full Text] [Related]
17. Big tumor regression induced by GM-CSF gene-modified 3LL tumor cells via facilitating DC maturation and deviation toward CD11c+CD8alpha+ subset. Lin Y; Xiong S; Zhang L; Zhang Y; Cai Y; Xu L; Chu Y DNA Cell Biol; 2007 Dec; 26(12):863-72. PubMed ID: 17760559 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of T cells derived from lymph nodes draining a poorly immunogenic tumor transduced to secrete granulocyte-macrophage colony-stimulating factor. Arca MJ; Krauss JC; Aruga A; Cameron MJ; Shu S; Chang AE Cancer Gene Ther; 1996; 3(1):39-47. PubMed ID: 8785710 [TBL] [Abstract][Full Text] [Related]
19. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production. Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699 [TBL] [Abstract][Full Text] [Related]
20. Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Yamaue H Int J Oncol; 2007 Oct; 31(4):931-9. PubMed ID: 17786327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]